SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-028788
Filing Date
2024-02-28
Accepted
2024-02-28 17:09:27
Documents
24
Period of Report
2024-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247473d1_8k.htm   iXBRL 8-K 37892
2 EXHIBIT 1.1 tm247473d1_ex1-1.htm EX-1.1 523910
3 EXHIBIT 4.1 tm247473d1_ex4-1.htm EX-4.1 110430
4 EXHIBIT 5.1 tm247473d1_ex5-1.htm EX-5.1 12798
5 EXHIBIT 99.1 tm247473d1_ex99-1.htm EX-99.1 11486
6 EXHIBIT 99.2 tm247473d1_ex99-2.htm EX-99.2 12259
11 GRAPHIC tm247473d1_ex5-1img001.jpg GRAPHIC 10889
12 GRAPHIC tm247473d1_ex5-1img002.jpg GRAPHIC 3772
13 GRAPHIC tm247473d1_ex99-1img001.jpg GRAPHIC 2903
14 GRAPHIC tm247473d1_ex99-2img001.jpg GRAPHIC 3027
  Complete submission text file 0001104659-24-028788.txt   1132216

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA nrxp-20240227.xsd EX-101.SCH 3245
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrxp-20240227_def.xml EX-101.DEF 26897
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrxp-20240227_lab.xml EX-101.LAB 36508
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrxp-20240227_pre.xml EX-101.PRE 25521
25 EXTRACTED XBRL INSTANCE DOCUMENT tm247473d1_8k_htm.xml XML 5316
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38302 | Film No.: 24696753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)